The global glucagon like peptide-1 (GLP-1) agonists market was valued at $31.3 billion in 2023, and is projected to reach $90.6 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
Report Code : A324075 | Pages : 216 | Category : Life Sciences
The global g-protein coupled receptor (GPCR) targeting market was valued at $3.7 billion in 2023, and is projected to reach $6.1 billion by 2033, growing at a CAGR of 5.2% from 2024 to 2033.
Report Code : A324091 | Pages : 216 | Category : Life Sciences
